Philippe Lambin

Citée par

	Toutes	Depuis 2019
Citations	75633	45178
indice h	128	85
indice i10	572	457

9000

4500

2250

6750

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024216 247 300 417 486 749 886 993 1392 1581 1787 1993 2197 2873 3413 4215 5176 5857 6761 8152 8740 8201 7406

Accès public

Tout afficher

288 articles

6 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Andre DekkerProfessor of Clinical Data Science, MAASTRO Clinic, Maastricht University, GROW, Maastricht UMC+Adresse e-mail validée de maastro.nl
Ralph T.H. LeijenaarPhDAdresse e-mail validée de maastrichtuniversity.nl
Wouter van ElmptMaastricht University Medical CentreAdresse e-mail validée de maastro.nl
Hugo AertsDirector AI in Medicine (AIM) @ Harvard-MGB | Professor @ MaastrichtUAdresse e-mail validée de dfci.harvard.edu
Ludwig DuboisMaastricht UniversityAdresse e-mail validée de maastrichtuniversity.nl
Henry C WoodruffThe D-Lab, Department of Precision Medicine, Maastricht UniversityAdresse e-mail validée de maastrichtuniversity.nl
Cary OberijeAdresse e-mail validée de maastrichtuniversity.nl
Bradly WoutersPrincess Margaret Cancer Centre, University Health Network, University of TorontoAdresse e-mail validée de uhn.ca
Frank HoebersRadiation Oncology (MAASTRO); Maastricht University; Brigham and Women's Hospital, Harvard MedicalAdresse e-mail validée de maastro.nl
Emmanuel Rios VelazquezBusiness Development Manager - Precision Health & Nutrition @imec - OnePlanet Research CenterAdresse e-mail validée de imec.nl
Ruud G.P.M. van StiphoutPrincipal Data Scientist at imec within OnePlanet Research CenterAdresse e-mail validée de imec.nl
Esther TroostResident in Radiation OncologyAdresse e-mail validée de uniklinikum-dresden.de
Catharina M.L. ZegersDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental BiologyAdresse e-mail validée de maastro.nl
Sean WalshRadiomics - Insight-based decision makingAdresse e-mail validée de radiomics.bio
Felix MottaghyDepartment of Nuclear Medicine, University Hospital RWTH Aachen UniversityAdresse e-mail validée de ukaachen.de
Erik RoelofsMAASTRO Clinic, Maastricht University, GROWAdresse e-mail validée de maastro.nl
Geert BosmansMaastro clinic, MaastrichtAdresse e-mail validée de maastro.nl
Robert GilliesChair of Cancer Physiology, H. Lee Moffitt Cancer CenterAdresse e-mail validée de moffitt.org
Johan van SoestMaastricht UniversityAdresse e-mail validée de maastrichtuniversity.nl
Janita van TimmerenRadboudumcAdresse e-mail validée de radboudumc.nl

Suivre

Philippe Lambin

Professor of Precision Medicine, Maastricht University & Scientist ULB

Adresse e-mail validée de maastrichtuniversity.nl - Page d'accueil

Radiomics Tumour hypoxia Decision Support Systems Immunotherapy Living medicine


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Radiomics: extracting more information from medical images using advanced feature analysis P Lambin, E Rios-Velazquez, R Leijenaar, S Carvalho, ... European journal of cancer 48 (4), 441-446, 2012	5486	2012
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach HJWL Aerts, ER Velazquez, RTH Leijenaar, C Parmar, P Grossmann, ... Nature communications 5 (1), 4006, 2014	5090	2014
Radiomics: the bridge between medical imaging and personalized medicine P Lambin, RTH Leijenaar, TM Deist, J Peerlings, EEC De Jong, ... Nature reviews Clinical oncology 14 (12), 749-762, 2017	4462	2017
The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping A Zwanenburg, M Vallières, MA Abdalah, HJWL Aerts, V Andrearczyk, ... Radiology 295 (2), 328-338, 2020	2840	2020
Radiomics: the process and the challenges V Kumar, Y Gu, S Basu, A Berglund, SA Eschrich, MB Schabath, K Forster, ... Magnetic resonance imaging 30 (9), 1234-1248, 2012	2317	2012
Imaging biomarker roadmap for cancer studies JPB O'connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ... Nature reviews Clinical oncology 14 (3), 169-186, 2017	1110	2017
Machine learning methods for quantitative radiomic biomarkers C Parmar, P Grossmann, J Bussink, P Lambin, HJWL Aerts Scientific reports 5 (1), 1-11, 2015	1047	2015
The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5 KMA Rouschop, T van den Beucken, L Dubois, H Niessen, J Bussink, ... The Journal of clinical investigation 120 (1), 127-141, 2010	918	2010
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma TP Coroller, P Grossmann, Y Hou, ER Velazquez, RTH Leijenaar, ... Radiotherapy and Oncology 114 (3), 345-350, 2015	787	2015
Low-dose hypersensitivity: current status and possible mechanisms MC Joiner, B Marples, P Lambin, SC Short, I Turesson International Journal of Radiation Oncology* Biology* Physics 49 (2), 379-389, 2001	783	2001
Robust radiomics feature quantification using semiautomatic volumetric segmentation C Parmar, E Rios Velazquez, R Leijenaar, M Jermoumi, S Carvalho, ... PloS one 9 (7), e102107, 2014	658	2014
A literature review of electronic portal imaging for radiotherapy dosimetry W Van Elmpt, L McDermott, S Nijsten, M Wendling, P Lambin, B Mijnheer Radiotherapy and oncology 88 (3), 289-309, 2008	636	2008
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized … V Valentini, RGPM Van Stiphout, G Lammering, MA Gambacorta, ... Journal of clinical oncology 29 (23), 3163-3172, 2011	570	2011
Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach JA Langendijk, P Lambin, D De Ruysscher, J Widder, M Bos, M Verheij Radiotherapy and Oncology 107 (3), 267-273, 2013	560	2013
Spatial genomic heterogeneity within localized, multifocal prostate cancer PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ... Nature genetics 47 (7), 736-745, 2015	547	2015
Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer C Parmar, RTH Leijenaar, P Grossmann, E Rios Velazquez, J Bussink, ... Scientific reports 5 (1), 11044, 2015	498	2015
The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis RTH Leijenaar, G Nalbantov, S Carvalho, WJ Van Elmpt, EGC Troost, ... Scientific reports 5 (1), 11075, 2015	479	2015
Stability of FDG-PET radiomics features: an integrated analysis of test-retest and inter-observer variability RTH Leijenaar, S Carvalho, ER Velazquez, WJC Van Elmpt, C Parmar, ... Acta oncologica 52 (7), 1391-1397, 2013	476	2013
Predicting outcomes in radiation oncology—multifactorial decision support systems P Lambin, RGPM Van Stiphout, MHW Starmans, E Rios-Velazquez, ... Nature reviews Clinical oncology 10 (1), 27-40, 2013	458	2013
Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer D De Ruysscher, M Pijls-Johannesma, SM Bentzen, A Minken, ... Journal of Clinical Oncology 24 (7), 1057-1063, 2006	427	2006

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs